{
    "title": "U.S. FDA approves new Bristol Myers cancer immunotherapy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10629441/U-S-FDA-approves-new-Bristol-Myers-cancer-immunotherapy.html",
    "date": "2022-03-18",
    "keywords": [
        "combination",
        "cancer",
        "relatlimab",
        "drug",
        "treatment",
        "melanoma",
        "inhibitor",
        "class",
        "company",
        "hirawat",
        "immune",
        "system",
        "opdivo",
        "bristol",
        "reporting",
        "march",
        "co",
        "friday",
        "form",
        "skin",
        "food",
        "administration",
        "lymphocyteactivation",
        "gene",
        "use",
        "brand",
        "name",
        "time",
        "measure",
        "survival",
        "medicine",
        "immunotherapy",
        "bodys",
        "fight",
        "protein",
        "pd1",
        "officer",
        "samit",
        "interview",
        "function",
        "component",
        "performance",
        "hypothesis",
        "applicability",
        "therapy",
        "excess",
        "year",
        "tumor",
        "colorectal",
        "lung",
        "liver",
        "sharma",
        "bengaluru",
        "editing",
        "bill",
        "berkrot",
        "leslie",
        "adler"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}